Australia markets closed

AnaptysBio, Inc. (ANAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
19.34+0.47 (+2.52%)
As of 10:57AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 515.50M
Enterprise value 142.41M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)29.61
Price/book (mrq)5.85
Enterprise value/revenue 8.30
Enterprise value/EBITDA -0.99

Trading information

Stock price history

Beta (5Y monthly) -0.29
52-week change 3-9.37%
S&P500 52-week change 321.08%
52-week high 327.50
52-week low 313.36
50-day moving average 322.96
200-day moving average 320.06

Share statistics

Avg vol (3-month) 3327.33k
Avg vol (10-day) 3312.35k
Shares outstanding 527.32M
Implied shares outstanding 626.76M
Float 814.73M
% held by insiders 10.39%
% held by institutions 1111.18%
Shares short (15 Apr 2024) 44.27M
Short ratio (15 Apr 2024) 49.52
Short % of float (15 Apr 2024) 423.38%
Short % of shares outstanding (15 Apr 2024) 415.95%
Shares short (prior month 15 Mar 2024) 44.14M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-386.41%

Management effectiveness

Return on assets (ttm)-18.47%
Return on equity (ttm)-93.44%

Income statement

Revenue (ttm)17.16M
Revenue per share (ttm)0.64
Quarterly revenue growth (yoy)32.30%
Gross profit (ttm)N/A
EBITDA -156.42M
Net income avi to common (ttm)-163.62M
Diluted EPS (ttm)-6.08
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)390.9M
Total cash per share (mrq)14.61
Total debt (mrq)328.62M
Total debt/equity (mrq)373.00%
Current ratio (mrq)10.87
Book value per share (mrq)3.31

Cash flow statement

Operating cash flow (ttm)-120.8M
Levered free cash flow (ttm)-73.42M